Supporting equitable access to legal and regulated psychedelic medicine for all Canadians.
Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.
Recent Blog Articles
September 1st, 2021 MAPS Canada is pleased to announce the appointment of Scott Bernstein as our new Executive Director. A lawyer based in Vancouver, BC,
Neural plasticity has been the subject of much debate, and hype both in the scientific community as well as the general public. At the same
Introduction Over the past several years, MDMA (also known as Ecstasy/Molly) has been making waves in the realms of drug research and therapy, with many